Inogen, Inc (INGN) analyst actions
Rating and price-target actions on INGN in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the INGN overview →
No INGN analyst action events in the measured window.
Nothing matched in the current window — the INGN overview has every event we measure for this name.
Get an email when INGN moves on news →Keep exploring
More INGN: earnings → · SEC filings → · INGN overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| The Joint Corp. (JYNT) | 200 | 0.00% | 45% |
| ProPhase Labs, Inc. (PRPH) | 198 | -0.18% | 44% |
| Protalix BioTherapeutics, Inc. (DE) (PLX) | 197 | 0.00% | 43% |
| AC Immune SA (ACIU) | 195 | -0.43% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.